Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Dualitybio Inc.

Home Clinical Trial Sponsors and OrganizationsDualitybio Inc.

Dualitybio Inc.

ACTIVE

3524 Silverside Rd Ste 35B, 上海市（市辖区）, 上海市, United StatesPrivateEstablished: 2020-04-26

Part of Duality Biologics (Suzhou) Co., Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

15

4 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2020

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

10

66.7%

Phase 3

3

20.0%

Phase 2

2

13.3%

Trial Status Distribution

Active, not recruiting

3

20.0%

Not yet recruiting

1

6.7%

Recruiting

11

73.3%

Clinical Trials

Trials sponsored by this organization (15)

DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

May 2026102 participants

A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors

Jan 2026127 participants

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

Sep 2025253 participants

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Jul 2025450 participants

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Oct 2024148 participants

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Sep 2024360 participants

A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

Active, not recruiting

Jan 2024228 participants

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Active, not recruiting

Jan 2024541 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials15
Approvals
News

Back to Organizations